National Observatory of Children Hospitalized for Bronchiolitis
NCT ID: NCT06112132
Last Updated: 2024-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2500 participants
OBSERVATIONAL
2023-10-15
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Outcome of Infants With or Without Documented Wheezing During Bronchiolitis
NCT04811248
Acute Bronchiolitis in Infants and Allergic Asthma
NCT03915197
Effectiveness of Nirsevimab in Children Hospitalised With RSV Bronchiolitis
NCT06030505
Parental Assessment of the Quality of Life of Infants With Bronchiolitis Episodes
NCT04135430
Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation
NCT06842238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In one of the 6 study sites
* From October 15, 2023
* For acute bronchiolitis defined according to current national and international recommendations
* Hospitalized from the pediatric emergency department.
Exclusion Criteria
1 Day
12 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Association Clinique Thérapeutique Infantile du val de Marne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Levy Corinne
Role: STUDY_DIRECTOR
Association Clinique Thérapeutique Infantile du val de Marne
Jeziorski Eric
Role: PRINCIPAL_INVESTIGATOR
CHU Montpellier, Service Urgence et Post-urgences pédiatrique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ACTIV
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Jeziorski E, Ouziel A, Cotillon M, Bridonneau C, Bizot E, Basse C, Portefaix A, Dubos F, Bechet S, Domitien L, Jaillet C, Abrudan S, Kramer R, Gajdos V, Launay E, Basmaci R, Gillet Y, Cohen R, Levy C. Impact of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis in Hospitalized Infants: A Real-World Study. Pediatr Infect Dis J. 2025 Apr 1;44(4):e124-e126. doi: 10.1097/INF.0000000000004630. Epub 2024 Nov 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OVNI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.